Waiv

Catalyzing precision medicine with AI-enabled tests that accelerate biomarker discovery & detection, outcome prediction, and treatment-response assessment across oncology.

Health and bio

Latest funding

$33M Series A · April 24, 2026

Source: fundraisingfox.com

Funding history ↓

Website: waiv.com.

LinkedIn: we-are-waiv.

Category: Health and bio.

Stage: Series A.

Last round: Apr 24, 2026 · 202 days ago.

On Recent Funding since: Nov 6, 2026.

Signals

Website registeredDec 23, 1999 (26 years old)

Funding rounds

April 24, 2026
Series A · $33M
Source: fundraisingfox.com
December 23, 1999
Website created

Founders and team

MS
Meriem Sefta CEO & Co-founder

source: waiv.com
LG
Lionel Guillou Co-founder & CSTO

LinkedIn · source: waiv.com

Companies like Waiv

IIDRx$120M Series B+ · Aug 2024
MMindpeak$15.3M Series A · Oct 2024
MMARAbio$19M Series A · Oct 2024
NNanoligent$14.01M Seed · Oct 2025
BBiotwin
PPear Suite$7.6M Series A · Oct 2025

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/waiv (get a free API key).